Showing results (51-60 of 94) with videos related to

Sort By:
Pageof 10
BMJ Open|March 15, 2024
Adjuvant chemotherapy and survival outcomes in older women with HR+/HER2- breast cancer: a propensity score-matched retrospective cohort study using the SEER databaseXindi Ma, Shang Wu, Xiangmei Zhang, et al.
Cancer Communications (London, England)|June 28, 2024
Disitamab vedotin, a HER2-directed antibody-drug conjugate, in patients with HER2-overexpression and HER2-low advanced breast cancer: a phase I/Ib studyJiayu Wang, Yunjiang Liu, Qingyuan Zhang, et al.
Cancer Biology & Therapy|December 20, 2024
Knockdown of NDUFAF6 inhibits breast cancer progression via promoting mitophagy and apoptosisShang Wu, Xindi Ma, Xiangmei Zhang, et al.
Clinical Breast Cancer|June 3, 2020
A Randomized Parallel Controlled Phase II Trial of Recombinant Human Endostatin Added to Neoadjuvant Chemotherapy for Stage III Breast CancerXiangmei Zhang, Zhenzhen Zhang, Miao Cao, et al.
Cancer Biotherapy & Radiopharmaceuticals|September 15, 2021
Apatinib Combined with Paclitaxel and Cisplatin Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cell CarcinomaJidong Zhao, Ming He, Jie Li, et al.
International Journal of General Medicine|August 25, 2021
The Diagnostic Value of Serum Exosomal Has_circ_0000615 for Breast Cancer PatientsJiani Liu, Xinyu Peng, Yinfeng Liu, et al.
Oncology Research|July 4, 2025
Tumor-expressing PD-L1 regulates NT5E expression through MAPK/ERK pathway in triple-negative breast cancerCheng Cheng, Chao Shi, Shang Wu, et al.
The Breast Journal|December 25, 2025
Fear of Cancer Recurrence Contributes Largely to Patient Anxiety and Depression and Quality of Life in a Prospective Cohort of Chinese Breast Cancer Patients for Postoperative RadiotherapyZhensheng Li, Yunjiang Liu, Yue Li, et al.
Frontiers in Microbiology|November 29, 2024
Screening and genome analysis of heat-resistant and antioxidant lactic acid bacteria from Holstein cow milkJiali Wang, Yunjiang Liu, Haohong Zheng, et al.
Frontiers in Immunology|May 10, 2024
Identification of molecular subtypes based on chromatin regulator-related genes and experimental verification of the role of ASCL1 in conferring chemotherapy resistance to breast cancerYilun Li, Xiaolu Yang, Cuizhi Geng, et al.
Pageof 10